Elena Santagostino
0000-0001-9639-6422
Publication & Citation Trends
Publications
0 total
Bleed Treatment Outcomes from the XTEND-ed Study in Patients Aged 50 Years and Older
Cited by 0
Semantic Scholar
Outcomes in participants switching from FVIII replacement therapy to efanesoctocog alfa prophylaxis in XTEND-1: a post hoc analysis
Cited by 0
Semantic Scholar
Challenges and Opportunities in Post-Marketing Reporting of Factor VIII Inhibitors With Efanesoctocog Alfa.
Cited by 0
Semantic Scholar
Perioperative Management With Efanesoctocog Alfa in Patients With Haemophilia A in the Phase 3 XTEND‐1 and XTEND‐Kids Studies
Cited by 2
Semantic Scholar
A Phase 1, Open-Label Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Intravenous Injection of Efanesoctocog Alfa in Adults with Type 2N or Type 3 von Willebrand Disease.
Cited by 4
Semantic Scholar
Post hoc analysis of bleeding episodes and clinically relevant pharmacokinetic parameters among children <12 years old with severe haemophilia A receiving once-weekly efanesoctocog alfa prophylaxis in the XTEND-Kids phase 3 multinational trial.
Cited by 0
Semantic Scholar
Clinical outcomes up to 4 years of once-weekly efanesoctocog alfa prophylaxis in previously treated adults, adolescents, and children with severe hemophilia A: Interim analysis of the Phase 3 XTEND-ed long-term extension study
Cited by 0
Semantic Scholar
HTRS2025.P2.60 SYNOVIIIUS: Prospective Interventional Study of Effectiveness of Efanesoctocog Alfa Prophylaxis for Synovial Hypertrophy in Patients With Hemophilia A — Study Design
Cited by 0
Semantic Scholar
Research Topics
Hemophilia Treatment and Research
(322)
Platelet Disorders and Treatments
(140)
Blood Coagulation and Thrombosis Mechanisms
(111)
Coagulation, Bradykinin, Polyphosphates, and Angioedema
(67)
Hemostasis and retained surgical items
(50)
Affiliations
Université Claude Bernard Lyon 1
Cleveland State University
Northwestern University
Rush University Medical Center
Boston Children's Hospital